Matthew R. Henn serves as Executive at Seres Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Matthew R. Henn has executed 16 insider transactions totaling $2.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 16, 2024 involved selling 923 shares valued at $775.
Matthew R. Henn currently holds 67,247 shares of Seres Therapeutics, Inc. (MCRB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew R. Henn has been a net seller of MCRB stock. They have purchased $0 and sold $2.5M worth of shares.
Matthew R. Henn's most recent insider trade was on Aug 16, 2024, when they sold 923 shares at $0.84 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Planned |
| May 15, 2024 | MCRB | $0 | Option Exercise | 2,812 | $N/A | Planned |
| May 15, 2024 | MCRB | $838 | Sale | 891 | $0.94 | Planned |
| Feb 16, 2024 | MCRB | $4.5K | Sale | 4,170 | $1.08 | Planned |
| Feb 15, 2024 | MCRB | $0 | Option Exercise | 11,250 | $N/A | Planned |
| Oct 30, 2023 | MCRB | $5.2K | Sale | 3,886 | $1.35 | Planned |
| Oct 27, 2023 | MCRB | $0 | Option Exercise | 12,623 | $N/A | Planned |
| Jul 5, 2022 | MCRB | $150.0K | Award | 47,619 | $3.15 | Discretionary |
| Dec 1, 2020 | MCRB | $18.5K | Option Exercise | 26,000 | $0.71 | Discretionary |
| Dec 1, 2020 | MCRB | $1.5M | Sale | 55,706 | $26.56 | Discretionary |
| Dec 1, 2020 | MCRB | $723.9K | Sale | 26,265 | $27.56 | Discretionary |
| Dec 1, 2020 | MCRB | $278.9K | Sale | 9,841 | $28.34 | Discretionary |
| Dec 1, 2020 | MCRB | $259.6K | Option Exercise | 26,250 | $9.89 | Discretionary |
| Dec 1, 2020 | MCRB | $165.6K | Option Exercise | 27,562 | $6.01 | Discretionary |
| Jan 26, 2020 | MCRB | $0 | Option Exercise | 7,500 | $N/A | Discretionary |